Merck
MRK
#47
Rank
S$361.26 B
Marketcap
S$146.12
Share price
-1.22%
Change (1 day)
17.05%
Change (1 year)

EPS for Merck (MRK)

EPS in 2025 (TTM): S$9.49

According to Merck's latest financial reports the company's current EPS (TTM) is S$9.33. an increase over its 2024 EPS that were of S$8.63.

EPS history for Merck from 2011 to 2025

Annual EPS

Year EPS Change
2025S$9.297.71%
2024S$8.634308.46%
2023S$0.20-97.32%
2022S$7.3210.92%
2021S$6.6084.68%
2020S$3.57-27.2%
2019S$4.9163.44%
2018S$3.00151.11%
2017S$1.20-54.58%
2016S$2.6330.21%
2015S$2.02-61.99%
2014S$5.32180.51%
2013S$1.89-31.82%
2012S$2.786.62%
2011S$2.61

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
S$14.22 52.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$9.40 0.73%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
S$1.74-81.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
S$4.79-48.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$29.39 215.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$18.29 96.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
S$2.64-71.74%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
S$3.79-59.35%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
S$4.81-48.43%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
S$1.58-83.03%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel